HEALTH TIPS.: Reclassification Recommendations for Drug in ‘Magic Mushrooms’ - Johns Hopkins researchers suggest that if it clears phase III clinical trials, psilocybin should be re-categorized from a schedule I drug to a schedule IV drug such as prescription sleep aids, but with tighter control.

Thursday 27 September 2018

Reclassification Recommendations for Drug in ‘Magic Mushrooms’ - Johns Hopkins researchers suggest that if it clears phase III clinical trials, psilocybin should be re-categorized from a schedule I drug to a schedule IV drug such as prescription sleep aids, but with tighter control.

Reclassification Recommendations for Drug in ‘Magic Mushrooms’ - Johns Hopkins researchers suggest that if it clears phase III clinical trials, psilocybin should be re-categorized from a schedule I drug to a schedule IV drug such as prescription sleep aids, but with tighter control.

submitted by /u/mvea
[link] [comments]

from Health https://ift.tt/2IlRqYe
via IFTTT

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)